Current Pharmaceutical Biotechnology

Papers
(The H4-Index of Current Pharmaceutical Biotechnology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Acknowledgement to Reviewers86
Strategy of Virtual Screening based Discovery of HSP90 C-terminal Inhibitors and Network Pharmacological Analysis50
Potential Pathogens Associated with Colorectal Cancer48
Genotoxic Impurities in Critical Analysis of Product Development: Recent Advancements, Patents, and Current Challenges45
Tryptophan Stability and Palatability in the Food Formulation: A Review45
Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders40
Foldable/Expandable Gastro-retentive Films Based on Starch and Chitosan as a Carrier For Prolonged Release of Resveratrol37
Protective Role of Glibenclamide and Magnesium Sulfate in Fructoseinduced Type 2 Diabetes Mellitus34
An Exploration of Organoid Technology: Present Advancements, Applications, and Obstacles33
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders32
Pharmacological Action and Research Progress of Taraxasterol31
Hydrogel Breakthroughs in Biomedicine: Recent Advances and Implications29
Xiaoyao Pill Improves the Affective Dysregulation of Sleep-deprived Female Mice by Inhibiting Brain Injury and Regulating the Content of Monoamine Neurotransmitter29
Nerolidol-potential Therapeutic Agent for Various Neurological Disorders via its Antioxidative Property28
Review on Natural Bioactive Products as Radioprotective Therapeutics: Present and Past Perspective27
A Review on Edible Vaccines and Biopharmaceutical Products from Plants26
FDA-approved CAR T-cell Therapy: A Decade of Progress and Challenges25
Spray Drying: A Promising Technique for Inhalable Vaccine Development25
Polygonati Rhizoma Alleviates Vascular Dementia through Regulating Microglial Polarization Transitions Mediated by NF-κB/NLRP3 Pathway25
Development of Daruharidra (Berberis aristata) Based Biogenic Cadmium Sulfide Nanoparticles: Their Implementation as Antibacterial and Novel Therapeutic Agents against Human Breast and Ovarian Cancer24
Novel Leflunomide Analog, UTLOH-4e, Ameliorates Gouty Arthritis Induced by Monosodium Urate Via NF-κB/NLRP3 Signaling Pathway24
WITHDRAWN: Current Synopsis on siRNA Therapeutics as a Novel Anti- Cancer and Antiviral Strategy: Progress and Challenges24
Nanogels as Drug Delivery Carrier: A Narrative Review on Formulation Techniques, Characterization, Applications and Patents23
Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme23
Evolving Advances in the Cosmetic use of Probiotics and Postbiotics: Health, Regulatory and Marketing Aspects23
0.19158792495728